Xinglong Qu

Xinglong Qu

Auto-generated profile, based on publicly available information

Xinglong Qu

Department of Surgical Oncology, Shanghai Cancer Center Minhang Branch Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2019 in Cells
Verified
Journal Article
Open access
PDF file
WSWei Sun
Wei Sun
BWBing Wang
Bing Wang
XQXing-Long Qu
Xing-Long Qu
BZBi-Qiang Zheng
Bi-Qiang Zheng
WHWending Huang
Wending Huang
YCYong Chen
Yong Chen
Background: The present study was designed to explore the underlying role of hypoxia-inducible factor 1α (HIF-1α) in reactive oxygen species (ROS) formation and apoptosis in osteosarcoma (OS) cells induced by hypoxia. Methods: In OS cells, ROS accumulated and apoptosis increased within 24 h after exposure to low HIF-1α expression levels. A co-expression analysis showed that HIF was positively correlated with Forkhead box class O1 (FoxO1) expression and negatively correlated with CYP-related genes from the National Center for Biotechnology Information’s Gene Expression Omnibus (NCBI GEO) datasets. Hypoxia also considerably increased HIF-1α and FoxO1 expression. Moreover, the promoter region of FoxO1 was directly regulated by HIF-1α. We inhibited HIF-1α via siRNA and found that the ROS accumulation and apoptosis induced by hypoxia in OS cells decreased. In this study, a murine xenograft model of BALB-c nude mice was adopted to test tumour growth and measure the efficacy of 2-ME + As2O3 treatment. Results: Ad interim knockdown of HIF-1α also inhibited manganese-dependent superoxide dismutase (MnSOD), catalase and sestrin 3 (Sesn3) expression in OS cells. Furthermore, hypoxia-induced ROS formation and apoptosis in OS cells were associated with CYP450 protein interference and were ablated by HIF-1α silencing via siRNA. Conclusions: Our data reveal that HIF-1α inhibits ROS accumulation by directly regulating FoxO1 in OS cells, which induces MnSOD, catalase and Sesn3 interference, thus resulting in anti-oxidation effects. The combination of an HIF-1α inhibitor (2-mercaptoethanol,2-ME) and ROS inducer (arsenous oxide, As2O3) can prohibit proliferation and migration and promote apoptosis in MG63 cells in vitro while inhibiting tumour growth in vivo.

13 January 2022 in Frontiers in Surgery
Verified
Journal Article
Open access
HZHongqiang Zhang
Hongqiang Zhang
WHWending Huang
Wending Huang
QFQi Feng
Qi Feng
WSWei Sun
Wei Sun
WYWangjun Yan
Wangjun Yan
YCYong Chen
Yong Chen
Objective: To investigate risk factors of local recurrence of synovial sarcoma and the impact of local recurrence on survival.Methods: We retrospectively reviewed clinical data of patients with II to IIIB (AJCC8) synovial sarcoma who underwent surgery at our center between March 2005 and December 2016. Data relating clinicopathological factors, treatment and prognosis were collected. The impact of local recurrence on overall survival (OS), local recurrence-free survival (LRFS), and distant relapse-free survival (DRFS) were analyzed. The prognostic factors associated with local recurrence were also analyzed using Kaplan-Meier Curves and Cox regression analysis.Results: A total of 171 patients were included in this analysis. After a median follow-up of 48 months, 66 patients (38.6%) experienced local recurrence. The 5-year OS, LRFS, and DRFS rates of patients with local recurrence were 37.6, 6.1, and 24.1%, respectively. Multivariate analysis showed that larger initial tumors, multiple recurrences, positive resection margins, marginal resection, and lack of adjuvant therapy were associated with higher local recurrence.Conclusion: Local recurrence of synovial sarcoma is associated with distant metastasis and poor survival. Chemoradiation improves the prognosis of patients with local recurrence, in particular those for which recurrence occurs shortly after initial treatment.

27 May 2020 in Cancer Communications
Verified
Journal Article
Open access
PDF file
WSWei Sun
Wei Sun
HZHongqiang Zhang
Hongqiang Zhang
BZBiqiang Zheng
Biqiang Zheng
RZRuming Zhang
Ruming Zhang
CWChunmeng Wang
Chunmeng Wang
YCYong Chen
Yong Chen
Click on the article title to read more.

1 April 2016 in Oncology and Translational Medicine
Verified
Journal Article
Closed access
YCYuxiao Chai
Yuxiao Chai
YHYu Han
Yu Han
BWBing Wang
Bing Wang
YZYi Zhang
Yi Zhang
XQXinglong Qu
Xinglong Qu